What is Wearable Health's earnings per share (EPS)?

Wearable Health (WHSI) reported diluted earnings per share of $-0.00 for fiscal year 2023. This represents a 86.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Wearable Health Financials

WHSI

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2023 Currency USD FYE June

This page shows Wearable Health (WHSI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 0/100

Based on FY2023 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Wearable Health has an operating margin of -307.9%, meaning the company retains $-308 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -1247.2% the prior year.

Growth

Wearable Health's revenue declined 28.8% year-over-year, from $1.0M to $745K. This contraction results in a growth score of 0/100.

Liquidity

Wearable Health's current ratio of 0.04 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 0/100, which could limit financial flexibility.

Cash Flow

While Wearable Health generated -$1.3M in operating cash flow, capex of $9K consumed most of it, leaving -$1.3M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Piotroski F-Score Weak

3/9

Wearable Health passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.54x

For every $1 of reported earnings, Wearable Health generates $0.54 in operating cash flow (-$1.3M OCF vs -$2.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-212.4x

Wearable Health earns $-212.4 in operating income for every $1 of interest expense (-$2.3M vs $11K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$745K

YoY-28.8%

5Y CAGR-10.5%

10Y CAGR+5.1%

Wearable Health generated $745K in revenue in fiscal year 2023. This represents a decrease of 28.8% from the prior year.

EBITDA

-$2.3M

YoY+82.5%

Wearable Health's EBITDA was -$2.3M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 82.5% from the prior year.

Net Income

-$2.4M

YoY+81.7%

Wearable Health reported -$2.4M in net income in fiscal year 2023. This represents an increase of 81.7% from the prior year.

EPS (Diluted)

$-0.00

YoY+86.7%

Wearable Health earned $-0.00 per diluted share (EPS) in fiscal year 2023. This represents an increase of 86.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$1.3M

YoY+59.2%

Wearable Health generated -$1.3M in free cash flow in fiscal year 2023, representing cash available after capex. This represents an increase of 59.2% from the prior year.

Cash & Debt

$136K

YoY+93.1%

5Y CAGR+5.1%

10Y CAGR+139.4%

Wearable Health held $136K in cash against $0 in long-term debt as of fiscal year 2023.

Dividends Per Share

N/A

Shares Outstanding

1.56B

YoY+4.6%

Wearable Health had 1.56B shares outstanding in fiscal year 2023. This represents an increase of 4.6% from the prior year.

Margins & Returns

Gross Margin

35.9%

YoY-9.7pp

5Y CAGR-33.5pp

10Y CAGR-26.8pp

Wearable Health's gross margin was 35.9% in fiscal year 2023, indicating the percentage of revenue retained after direct costs. This is down 9.7 percentage points from the prior year.

Operating Margin

-307.9%

YoY+939.3pp

10Y CAGR-8.2pp

Wearable Health's operating margin was -307.9% in fiscal year 2023, reflecting core business profitability. This is up 939.3 percentage points from the prior year.

Net Margin

-320.6%

YoY+927.1pp

5Y CAGR-260.3pp

10Y CAGR-230.6pp

Wearable Health's net profit margin was -320.6% in fiscal year 2023, showing the share of revenue converted to profit. This is up 927.1 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$50K

YoY-87.3%

5Y CAGR+8.9%

Wearable Health invested $50K in research and development in fiscal year 2023. This represents a decrease of 87.3% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$9K

YoY-81.1%

Wearable Health invested $9K in capex in fiscal year 2023, funding long-term assets and infrastructure. This represents a decrease of 81.1% from the prior year.

WHSI Income Statement

Metric	FY23	FY22	FY21	FY19	FY18	FY16
Revenue	$745K-28.8%	$1.0M-25.0%	$1.4M+81.0%	$770K-21.1%	$976K-24.7%	$1.3M
Cost of Revenue	$477K-16.0%	$568K-34.6%	$869K+118.4%	$398K+52.3%	$261K-33.9%	$396K
Gross Profit	$268K-43.9%	$477K-9.0%	$525K+41.0%	$372K-47.9%	$715K-20.6%	$900K
R&D Expenses	$50K-87.3%	$391K	$0	$0	$0-100.0%	$32K
SG&A Expenses	$348K-14.9%	$409K-42.8%	$716K-8.4%	$781K-15.5%	$924K-32.7%	$1.4M
Operating Income	-$2.3M+82.4%	-$13.0M-312.6%	-$3.2M-627.4%	-$435K-77.9%	-$244K	N/A
Interest Expense	$11K-12.0%	$12K-94.5%	$221K-21.2%	$281K+716.9%	$34K-78.1%	$157K
Income Tax	$0	$0	$0	$0	$0	N/A
Net Income	-$2.4M+81.7%	-$13.0M-293.9%	-$3.3M-363.1%	-$715K-156.7%	-$279K+64.3%	-$780K
EPS (Diluted)	$-0.00+86.7%	$-0.01-90.5%	$-0.01	N/A	N/A	N/A

Metric	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22
Revenue	$127K-10.6%	$142K+4.1%	$137K-29.4%	$194K-2.2%	$198K-8.5%	$216K-4.0%	$226K+5.9%	$213K
Cost of Revenue	$83K+66.1%	$50K-59.2%	$123K-9.2%	$135K+36.0%	$99K-17.2%	$120K+8.8%	$110K-1.0%	$111K
Gross Profit	$44K-52.3%	$92K+557.0%	$14K-76.0%	$59K-40.6%	$99K+2.2%	$96K-16.3%	$115K+13.4%	$102K
R&D Expenses	$0-100.0%	$15K-68.0%	$48K	$0	$0-100.0%	$2K+105.6%	-$39K-118.7%	$210K
SG&A Expenses	$29K-63.9%	$80K-21.9%	$102K+22.4%	$84K+3.9%	$80K-1.9%	$82K-52.0%	$171K+91.7%	$89K
Operating Income	-$72K+78.6%	-$336K+37.3%	-$535K-11.6%	-$480K+7.7%	-$519K+31.7%	-$760K+20.7%	-$959K+87.0%	-$7.4M
Interest Expense	N/A	$3K+480.0%	$591-82.4%	$3K-2.2%	$3K0.0%	$3K+106.2%	-$56K-756.2%	$8K
Income Tax	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	$125K+562.5%	$19K+103.3%	-$578K-10.7%	-$522K+3.3%	-$540K+27.9%	-$749K+21.8%	-$958K+87.0%	-$7.4M
EPS (Diluted)	$0.00	$0.00	N/A	$-0.00	$0.00	$0.00	N/A	$-0.01

WHSI Balance Sheet

Metric	FY23	FY22	FY21	FY19	FY18	FY16
Total Assets	$223K-34.2%	$339K-62.7%	$908K+666.1%	$119K-48.5%	$230K-59.7%	$571K
Current Assets	$152K-48.8%	$297K-67.2%	$908K+707.8%	$112K-48.1%	$216K-58.5%	$521K
Cash & Equivalents	$136K+93.1%	$71K-91.7%	$847K+22037.7%	$4K-15.3%	$5K-95.8%	$106K
Inventory	$9K+21.1%	$7K	$0-100.0%	$5K-94.2%	$91K+1114.7%	$8K
Accounts Receivable	$379	$0-100.0%	$26K+109.1%	$12K-84.1%	$77K-0.7%	$78K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.8M+56.3%	$2.4M-42.9%	$4.3M+83.2%	$2.3M+32.8%	$1.7M+3.5%	$1.7M
Current Liabilities	$3.8M+55.5%	$2.4M-42.9%	$4.3M+121.1%	$1.9M+10.1%	$1.7M+35.3%	$1.3M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$3.6M-71.0%	-$2.1M+37.6%	-$3.4M-51.9%	-$2.2M-45.1%	-$1.5M-35.7%	-$1.1M
Retained Earnings	-$41.8M-6.1%	-$39.4M-49.5%	-$26.4M-39.4%	-$18.9M-3.9%	-$18.2M-28.3%	-$14.2M

Metric	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22
Total Assets	$90K-28.5%	$125K-43.8%	$223K+71.8%	$130K-37.8%	$209K-51.0%	$426K+25.7%	$339K-46.4%	$632K
Current Assets	$32K-47.3%	$61K-59.8%	$152K+190.5%	$52K-58.0%	$125K-62.8%	$336K+12.8%	$297K-49.4%	$588K
Cash & Equivalents	$410-96.2%	$11K-92.2%	$136K+733.2%	$16K-64.1%	$45K-82.2%	$256K+263.0%	$71K-87.6%	$570K
Inventory	$5K-40.2%	$9K0.0%	$9K-74.3%	$33K-48.1%	$64K+55.8%	$41K+483.2%	$7K	$0
Accounts Receivable	$27K+93.1%	$14K+3546.4%	$379-53.3%	$812-91.2%	$9K-44.7%	$17K	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.2M-10.8%	$3.6M-6.1%	$3.8M+25.5%	$3.0M+12.8%	$2.7M+9.1%	$2.5M+1.2%	$2.4M-2.2%	$2.5M
Current Liabilities	$3.2M-10.7%	$3.6M-6.1%	$3.8M+25.8%	$3.0M+17.7%	$2.6M+5.1%	$2.4M0.0%	$2.4M-2.2%	$2.5M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$3.1M+10.2%	-$3.4M+3.8%	-$3.6M-23.4%	-$2.9M-17.1%	-$2.5M-21.7%	-$2.0M+2.8%	-$2.1M-12.9%	-$1.9M
Retained Earnings	-$41.7M+0.3%	-$41.8M0.0%	-$41.8M-1.4%	-$41.2M-1.3%	-$40.7M-1.3%	-$40.2M-1.9%	-$39.4M-2.5%	-$38.5M

WHSI Cash Flow Statement

Metric	FY23	FY22	FY21	FY19	FY18	FY16
Operating Cash Flow	-$1.3M+58.8%	-$3.1M-164.8%	-$1.2M-786.2%	-$132K-26.5%	-$105K	N/A
Capital Expenditures	$9K-81.1%	$50K	$0	$0	$0	N/A
Free Cash Flow	-$1.3M+59.2%	-$3.2M-169.1%	-$1.2M-786.2%	-$132K-26.5%	-$105K	N/A
Investing Cash Flow	-$9K+81.1%	-$50K	$0	$0	$0	N/A
Financing Cash Flow	$1.4M-43.1%	$2.4M+17.8%	$2.0M+1434.3%	$132K+67.7%	$79K-91.6%	$933K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22
Operating Cash Flow	-$10K+94.1%	-$175K-48.7%	-$117K-10.6%	-$106K+78.5%	-$495K+11.8%	-$561K-28.7%	-$436K+49.6%	-$864K
Capital Expenditures	$0	$0	$0	$0	$0-100.0%	$9K	$0	$0
Free Cash Flow	-$10K+94.1%	-$175K-48.7%	-$117K-10.6%	-$106K+78.5%	-$495K+13.3%	-$571K-30.9%	-$436K+49.6%	-$864K
Investing Cash Flow	$0	$0	$0	$0	$0+100.0%	-$9K	$0	$0
Financing Cash Flow	$0-100.0%	$49K-79.3%	$237K+207.9%	$77K-72.9%	$284K-62.4%	$756K+1291.8%	-$63K+61.7%	-$166K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

WHSI Financial Ratios

Metric	FY23	FY22	FY21	FY19	FY18	FY16
Gross Margin	35.9%-9.7pp	45.6%+8.0pp	37.6%-10.7pp	48.3%-24.9pp	73.2%+3.8pp	69.4%
Operating Margin	-307.9%+939.3pp	-1247.2%-1020.4pp	-226.8%-170.4pp	-56.4%-31.4pp	-25.0%	N/A
Net Margin	-320.6%+927.1pp	-1247.7%-1010.0pp	-237.6%-144.8pp	-92.9%-64.3pp	-28.6%+31.7pp	-60.2%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-1070.2%+2778.4pp	-3848.6%-3483.7pp	-365.0%+238.8pp	-603.8%-482.6pp	-121.2%+15.5pp	-136.7%
Current Ratio	0.04-0.1	0.12-0.1	0.21+0.2	0.06-0.1	0.12-0.3	0.40
Debt-to-Equity	-1.06+0.1	-1.16+0.1	-1.27-0.2	-1.05+0.1	-1.15+0.4	-1.51
FCF Margin	-173.0%+128.9pp	-301.9%-217.7pp	-84.2%-67.0pp	-17.2%-6.5pp	-10.7%	N/A

Metric	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22
Gross Margin	34.6%-30.2pp	64.8%+54.5pp	10.3%-19.9pp	30.2%-19.6pp	49.8%+5.2pp	44.6%-6.5pp	51.1%+3.4pp	47.7%
Operating Margin	-56.3%+179.4pp	-235.8%+155.2pp	-391.0%-143.4pp	-247.6%+14.7pp	-262.3%+88.8pp	-351.1%+74.0pp	-425.1%+3041.0pp	-3466.1%
Net Margin	98.4%+85.1pp	13.3%+435.5pp	-422.2%-152.7pp	-269.5%+3.1pp	-272.6%+73.3pp	-345.9%+78.8pp	-424.7%+3034.5pp	-3459.3%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	139.8%+124.7pp	15.1%+274.0pp	-258.9%+143.0pp	-401.9%-143.4pp	-258.5%-82.8pp	-175.7%+106.8pp	-282.5%+882.7pp	-1165.2%
Current Ratio	0.010.0	0.02-0.0	0.04+0.0	0.02-0.0	0.05-0.1	0.14+0.0	0.12-0.1	0.24
Debt-to-Equity	-1.030.0	-1.04+0.0	-1.06-0.0	-1.04+0.0	-1.08+0.1	-1.21-0.0	-1.16+0.2	-1.34
FCF Margin	-8.1%+114.6pp	-122.7%-36.8pp	-85.9%-31.1pp	-54.8%+195.0pp	-249.8%+13.8pp	-263.6%-70.2pp	-193.3%+212.5pp	-405.8%

Note: Shareholder equity is negative (-$3.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.04), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Hear Atlast Holdings HRAL

$203K

Innerscope Hear INND

$51K

Cecors Inc CEOS

$2.2M

Cardiac Biotech Solutions Inc CBSC

$5.0M

United Health Pr UEEC

$13.2M

Frequently Asked Questions

What is Wearable Health's annual revenue?

Wearable Health (WHSI) reported $745K in total revenue for fiscal year 2023. This represents a -28.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Wearable Health's revenue growing?

Wearable Health (WHSI) revenue declined by 28.8% year-over-year, from $1.0M to $745K in fiscal year 2023.

Is Wearable Health profitable?

No, Wearable Health (WHSI) reported a net income of -$2.4M in fiscal year 2023, with a net profit margin of -320.6%.

What is Wearable Health's EBITDA?

Wearable Health (WHSI) had EBITDA of -$2.3M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.

What is Wearable Health's gross margin?

Wearable Health (WHSI) had a gross margin of 35.9% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.

What is Wearable Health's operating margin?

Wearable Health (WHSI) had an operating margin of -307.9% in fiscal year 2023, reflecting the profitability of core business operations before interest and taxes.

What is Wearable Health's net profit margin?

Wearable Health (WHSI) had a net profit margin of -320.6% in fiscal year 2023, representing the share of revenue converted into profit after all expenses.

What is Wearable Health's free cash flow?

Wearable Health (WHSI) generated -$1.3M in free cash flow during fiscal year 2023. This represents a 59.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Wearable Health's operating cash flow?

Wearable Health (WHSI) generated -$1.3M in operating cash flow during fiscal year 2023, representing cash generated from core business activities.

What are Wearable Health's total assets?

Wearable Health (WHSI) had $223K in total assets as of fiscal year 2023, including both current and long-term assets.

What are Wearable Health's capital expenditures?

Wearable Health (WHSI) invested $9K in capital expenditures during fiscal year 2023, funding long-term assets and infrastructure.

How much does Wearable Health spend on research and development?

Wearable Health (WHSI) invested $50K in research and development during fiscal year 2023.

How many shares does Wearable Health have outstanding?

Wearable Health (WHSI) had 1.56B shares outstanding as of fiscal year 2023.

What is Wearable Health's current ratio?

Wearable Health (WHSI) had a current ratio of 0.04 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.

What is Wearable Health's debt-to-equity ratio?

Wearable Health (WHSI) had a debt-to-equity ratio of -1.06 as of fiscal year 2023, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Wearable Health's return on assets (ROA)?

Wearable Health (WHSI) had a return on assets of -1070.2% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.

What is Wearable Health's cash runway?

Based on fiscal year 2023 data, Wearable Health (WHSI) had $136K in cash against an annual operating cash burn of $1.3M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Wearable Health's debt-to-equity ratio negative or unusual?

Wearable Health (WHSI) has negative shareholder equity of -$3.6M as of fiscal year 2023, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Wearable Health's Piotroski F-Score?

Wearable Health (WHSI) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Wearable Health's earnings high quality?

Wearable Health (WHSI) has an earnings quality ratio of 0.54x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Wearable Health cover its interest payments?

Wearable Health (WHSI) has an interest coverage ratio of -212.4x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Wearable Health?

Wearable Health (WHSI) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.